Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study

Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study

Abstract Hepatocellular carcinoma is a leading cause of cancer-related death, with unresectable HCC (uHCC) presenting considerable clinical challenges; treatment options are limited, warranting the combination of locoregional therapies. We compared the efficacy of transcatheter arterial embolization...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng Zhang, Yuyan Xu, Lei Cai, Shuyi Zhou, Jianan Feng, Shunjun Fu, Weidong Wang, Weichao Liang, Chang Li, Weixu Guo, Minghui Tan, Haisu Tao, Sulai Liu, Jian Yang, Mingxin Pan
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
TAE–HAIC
Targeted therapy
Immunotherapy
Hepatocellular carcinoma
Propensity score matching
Multicenter retrospective study
Online Access:https://doi.org/10.1038/s41598-025-08170-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-08170-4

Similar Items